ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2150

Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective

Pallavi Arun1, Nikita Parashar1, Sakshi Sharma1, Kanika Arora1, Vandana Padmanabhan1 and Alvaro Arjona2, 1Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 2Novartis Farmaceutica, S.A., Madrid, Madrid, Spain

Meeting: ACR Convergence 2024

Keywords: giant cell arteritis, glucocorticoids, Polymyalgia Rheumatica (PMR), Qualitative Research, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Analyzing social media conversations of patients (pts) and caregivers can be useful to understand the real-world perspectives thereby improving quality of healthcare.1 GCA and PMR are related systemic inflammatory disorders affecting older adults,2 and have a major negative effect on the quality of life (QOL) of pts. We aimed to understand the real-world patient journey and identify the unmet needs of pts with GCA and/or PMR through social media listening (SML).

Methods: Social media content originating from the US and Germany in English and German between Aug 1, 2022, and Aug 1, 2023 were extracted for GCA and PMR. Sprinklr tool was used to download social media posts, using a pre-specified search query. The extracted data were filtered by platforms catering to pts, caregivers and healthcare professionals (HCPs). Duplicate records, broken URLs, news, retweets, and blogs were excluded to obtain insightful data. Natural language processing was used to assess the relevance of posts, followed by manual analysis of filtered data to identify and map key themes and insights.

Results: In total, 21,844 conversations were extracted, of which 1001 filtered posts were manually analyzed. Of the total identifiable reporters (n=517), 90% (n=465) were from the US and mostly females (65%). Among the identifiable reporters, 63% of the conversations were related to PMR, 16% to GCA and 16% related to both GCA and PMR. The most common theme of conversation among pts and caregivers was “treatment” (33%), followed by symptoms (13%), HCP visits (10%), diagnosis (7%) and impact on QOL (7%). The unmet needs and concerns were mostly related to pt experiences with HCPs (perceived lack of disease awareness, delayed diagnosis, and HCPs being dismissive about symptoms) and treatments (side effects, lack of effective treatments, and difficult steroid-tapering journey) (Table). The symptoms of PMR and GCA impacted pts’ physical (n=69) and emotional (n=16) aspects of QOL. Pain (32%) and fatigue (14%) restricted pts with PMR from carrying out daily activities (71%) and caused difficulty in walking (36%). Pts with GCA experienced vision impairment (38%) and fatigue (38%). Sentiment of pts around various treatments (n=297) available for PMR and GCA was negative (61%), mostly driven by side effects/intolerability, inefficacy/waning efficacy and flare-ups during steroid tapering. From the overall responses related to treatment perceptions (n=41), glucocorticoids (GC) had a relatively negative perception (35%), whereas biologics had a more positive perception (27%) and were perceived as a safer alternative by pts. The burden of comorbidities associated with the use of GCs was also a recurrent concern.

Conclusion: To our knowledge, this is the first social media–based study exploring the perspectives of pts with GCA and PMR. The insights from SML reveal that PMR and GCA have a major impact on the QOL and there is a large unmet need for alternative safe and effective treatment options. There is also a need for greater disease awareness among HCPs to aid timely diagnosis and referral.

References:

  1. Zakkar MA, Lizotte DJ. J Healthc Inform Res. 2021;5(4):382-400.
  2. Weyand CM, Goronzy JJ. N Engl J Med. 2014;371(1):50-57.

Supporting image 1

Table. Most frequent HCP- and treatment-related unmet needs and concerns expressed by patients with PMR and GCA


Disclosures: P. Arun: Novartis, 3; N. Parashar: Novartis, 3; S. Sharma: Novartis, 3; K. Arora: Novartis, 3; V. Padmanabhan: Novartis, 3; A. Arjona: Novartis, 3.

To cite this abstract in AMA style:

Arun P, Parashar N, Sharma S, Arora K, Padmanabhan V, Arjona A. Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/understanding-unmet-needs-and-quality-of-life-impact-of-giant-cell-arteritis-gca-and-polymyalgia-rheumatica-pmr-using-social-media-a-patient-and-caregiver-perspective/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-unmet-needs-and-quality-of-life-impact-of-giant-cell-arteritis-gca-and-polymyalgia-rheumatica-pmr-using-social-media-a-patient-and-caregiver-perspective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology